Regeneron Pharmaceuticals (REGN) Financials: Revenue & Earnings
Score
Financial Summary
Regeneron Pharmaceuticals, Inc. (REGN) last printed $920.69. Equity value is $95.23B. Trailing earnings multiple 19.82. The revenue row is reported history.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| $4.86B | $5.87B | $6.71B | $6.56B | $8.5B | $16.07B | $12.17B | $13.12B | $14.2B | $14.34B |